quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:00·33d
PRRelease
Prothena Corporation plc logo

Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson's and Alzheimer's Disease at AD/PD™ 2026

PRTA· Prothena Corporation plc
Health Care
Original source

Companies

  • PRTA
    Prothena Corporation plc
    Health Care

Recent analyst ratings

  • May 28UpdateBofA Securities$4.00
  • May 27UpdateOppenheimer-
  • May 27UpdateJefferies$6.00
  • May 27UpdateCantor Fitzgerald-
  • Dec 20UpdateChardan Capital Markets$40.00
  • Jan 30UpdateBofA Securities$38.00

Related

  • INSIDER13d
    SEC Form 4 filed by Kingston Anne Evans
  • INSIDER13d
    SEC Form 3 filed by new insider Kingston Anne Evans
  • PR13d
    Prothena Announces Leadership Team Updates
  • SEC27d
    SEC Form DEFA14A filed by Prothena Corporation plc
  • SEC27d
    SEC Form DEF 14A filed by Prothena Corporation plc
  • PR45d
    Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy
  • INSIDER49d
    SEC Form 4 filed by Chief Scientific Officer Zago Wagner M.
  • INSIDER49d
    SEC Form 4 filed by Chief Accounting Officer Walker Karin L
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022